Cell Press

Cell Press is an academic publishing imprint specializing in high-impact scientific journals, particularly in the life sciences, biomedical research, and adjacent areas of physical and environmental science. It was established in 1974 by biologist and editor Benjamin Lewin around the journal Cell. The title was initially created as an independent journal and became known for publishing concise, conceptually significant research in cell biology. Its editorial model and reputation subsequently supported the development of a broader portfolio of specialist journals. The Cell Press portfolio includes Cell and a range of field-specific publications such as Molecular Cell, Neuron, Immunity, Cancer Cell, Developmental Cell, Current Biology, and Trends-branded journals. The portfolio spans molecular and cellular biology, neuroscience, immunology, cancer research, developmental biology, genomics, systems biology, ecology, and related disciplines. Many of its journals publish primary research alongside reviews, perspectives, commentaries, methods, and other forms of scholarly communication. The portfolio has also expanded beyond traditional biology into areas such as chemistry, energy, materials science, and sustainability through newer titles and partnerships. Cell Press journals are distributed digitally through Cell.com and Elsevier's wider publishing infrastructure, with print editions and institutional access arrangements available for relevant titles. The business serves researchers, universities, hospitals, government laboratories, learned societies, funders, and other scientific institutions worldwide. Its principal value proposition is editorial selectivity, specialist peer review, recognizable journal brands, and the dissemination and curation of research for professional audiences. Like other major scholarly publishers, Cell Press operates across subscription, hybrid open-access, and fully open-access models, depending on the journal and article route. The imprint became part of Elsevier in 1999. Under Elsevier, Cell Press retained a distinct editorial identity while benefiting from a larger international platform for production, online hosting, sales, licensing, author services, and distribution. Elsevier is part of RELX, a global information and analytics group. Cell Press therefore operates as a publishing brand rather than as an independently listed company. Cell Press's influence is closely associated with the visibility of its flagship journals and with the role those journals play in communicating consequential scientific findings. The brand has also participated in broader changes in scholarly publishing, including open-access distribution, data and resource sharing, preprint-linked workflows, article-level online publication, and efforts to improve research transparency. Its prominence has brought the same general debates that affect selective scientific publishing, including concerns about publication incentives, access costs, reproducibility, peer-review practices, and the use of journal-level metrics. These issues are sector-wide and do not by themselves establish a specific misconduct finding against Cell Press. The organization remains active as an international scientific publisher. Its current scope is best understood as a portfolio of journals and related editorial products rather than a single publication, with Cell continuing to serve as the central brand and a large network of companion titles serving specialized research communities.

Cell Press originated in 1974 with the launch of Cell by Benjamin Lewin. The journal was created during a period when molecular and cellular biology were rapidly expanding and when researchers needed venues capable of presenting technically complex findings with broad conceptual relevance. Cell developed a distinctive editorial identity centered on important mechanistic discoveries and influential biological ideas. Its name and reputation eventually became the foundation of a wider publishing imprint. During the following decades, Cell Press expanded through the creation or incorporation of journals serving neighboring research communities. Molecular Cell extended the portfolio into molecular mechanisms and regulation; Neuron focused on neuroscience; Immunity covered immunology; Cancer Cell addressed cancer biology and translational research; and Developmental Cell covered developmental and cellular processes. Other titles broadened the portfolio into general biology, methods, reviews, ecology, chemistry, energy, materials, and sustainability. The resulting group combined selective flagship journals with specialist publications aimed at defined scientific audiences. Cell Press became part of Elsevier in 1999. The transaction changed the imprint's corporate setting without eliminating its recognizable editorial identity. Elsevier supplied international production, sales, licensing, technology, and distribution capabilities, while Cell Press continued to operate through journal-specific editorial teams and brands. The imprint consequently became a prominent component of Elsevier's health and life-sciences publishing activities. The publishing environment changed substantially as Cell Press developed. Print journals were supplemented and then largely complemented by online publication, searchable archives, electronic access, article-level dissemination, and digital author workflows. Cell Press journals adopted or expanded forms of open-access publishing, including hybrid options in some established titles and fully open-access routes in selected newer journals. The imprint also participated in wider scholarly-publishing practices involving supplemental data, methods, resource reporting, preprints, peer-review policies, and efforts to make research outputs more discoverable and reproducible. Cell Press's history is therefore both the history of a journal brand and an example of consolidation in scholarly publishing. It moved from an independent, founder-led publication built around Cell to a multi-journal imprint within one of the world's largest academic publishing groups. Its continuing reputation rests on journal selectivity, editorial curation, and influence in the life sciences, while its operations are connected to the commercial, technological, and access policies of Elsevier and RELX. As of the present, Cell Press remains active and internationally distributed. Its journals serve academic laboratories, medical and research institutions, universities, funders, and other professional users. The imprint's principal challenge is balancing the prestige and selectivity associated with its brands against changing expectations regarding open access, affordability, research assessment, transparency, and equitable participation in scholarly communication.

• 1999

  Cell Press joins Elsevier

  [1]Cell Press 50th anniversary historycell.com

  Elsevier acquires Cell Press, placing the imprint within a larger international scholarly-publishing group.

• 1974

  Cell is founded

  [1]Cell Press 50th anniversary historycell.com

  Benjamin Lewin establishes Cell, the journal that becomes the foundation of the Cell Press imprint.

Selective, high-impact scientific publishing for life sciences and related research disciplines, combining specialist editorial brands with Elsevier's global scholarly-publishing infrastructure.

• General life-science research journal · 1974

  Cell

  Cell is the flagship journal of the imprint and publishes research and commentary across biology, with particular emphasis on findings considered broadly significant to the life sciences. It is the publication from which the Cell Press identity developed and remains the central reference point for the portfolio.

• Molecular biology journal

  Molecular Cell

  Molecular Cell focuses on molecular mechanisms underlying biological processes. Its coverage includes gene regulation, chromatin, signaling, structural biology, RNA biology, and related areas, providing a specialist venue within the Cell Press portfolio for mechanistic molecular research.

• Neuroscience journal

  Neuron

  Neuron is a neuroscience journal covering work from molecular and cellular neuroscience through systems, cognitive, and clinical-adjacent research. It is one of the imprint's established specialist titles and serves researchers studying the nervous system across multiple levels of analysis.

• Immunology journal

  Immunity

  Immunity publishes research on immune-system biology, including cellular and molecular mechanisms, host defense, inflammation, immunopathology, and interactions between immunity and disease. The journal is a major specialist component of Cell Press's biomedical portfolio.

• Cancer research journal

  Cancer Cell

  Cancer Cell covers fundamental, translational, and clinically relevant cancer research. Its subject range includes tumor biology, genetics, microenvironment, therapeutics, immuno-oncology, and mechanisms of treatment response and resistance.

• Developmental biology journal

  Developmental Cell

  Developmental Cell publishes work on the cellular and molecular basis of development, including morphogenesis, differentiation, tissue organization, cell polarity, and related mechanisms. It connects developmental biology with broader questions in cell biology.

• General biology journal

  Current Biology

  Current Biology combines primary research with reviews, discussions, and other editorial formats across the biological sciences. Its broad scope complements the more narrowly specialized journals in the Cell Press portfolio.

• Review journal series

  Trends journals

  The Trends series consists primarily of review-oriented journals covering specialized disciplines. These publications synthesize developments, identify emerging research directions, and provide field overviews for researchers and advanced scientific readers.

• 1999

  Integration into ElsevierM&A

  Background

  Cell Press had developed from the Cell journal into a broader scientific publishing imprint, while Elsevier was expanding its international scholarly-journal portfolio.

  Action taken

  Elsevier acquired Cell Press and incorporated it into its publishing operations while maintaining the Cell Press journal identity.

  Aftermath

  Cell Press continued as a distinct imprint within Elsevier and gained access to the parent company's global distribution, technology, and institutional-sales infrastructure.

  Source

• 1999

  Elsevier acquired Cell Press[1]Cell Press 50th anniversary historycell.com

  M&A

  Cell Press became part of Elsevier, creating the ownership structure under which the imprint operates today.

1. 1Cell Press 50th anniversary historycell.com
2. 2Cell Press journalscell.com
3. 3Elsevier: Cell Presselsevier.com